ESC 365 - Welcome and introductions Optimising patient outcomes: A guide to the initiation of SGLT2 inhibitors from first-hand experience.

Open Access

Welcome and introductions Optimising patient outcomes: A guide to the initiation of SGLT2 inhibitors from first-hand experience.

Session: SGLT2 inhibitors: optimising heart failure treatment

Topic: Chronic Heart Failure, Other

Speaker: Professor G. Fonarow (Los Angeles, US)

Sponsored by AstraZeneca

Event: Heart Failure 2021 Online Congress

Congress Session

About the speaker

Professor Gregg Fonarow

UCLA MEDICAL CENTER CARDIOLOGY, Los Angeles (United States of America)

1 presentation

0 follower

2 more presentations in this session

Considerations for therapy optimisation.

Speaker: Professor C. Lam (Singapore, SG)

Live Q&A.

Access the full session

SGLT2 inhibitors: optimising heart failure treatment

Speakers: Professor G. Fonarow, Professor C. Lam

About the event

Heart Failure 2021 Online Congress

29 June - 1 July 2021

Sessions Presentations

Congress

Related content

Open Access

Hot topics in atrial fibrillation.

5 April 2022

Open Access

Cardiogenic shock: state of the art 2022 - discussion.

19 March 2022

Open Access

Pharmacological treatment: how to choose your drug (if any)

19 March 2022

This platform is supported by